BioHealth News Archive
Trump FDA Chief Scott Gottlieb Isn’t Pharma’s BFF After All – Bloomberg Gadfly
Scott Gottlieb seems like the pharmaceutical industry's idea of a dream FDA Commissioner, with pharma ties and an ideological bent toward deregulation. {iframe}https://www.bloomberg.com/gadfly/articles/2018-01-02/trump-fda-chief-scott-gottlieb-isn-t-pharma-s-bff-after-all{/iframe}
Read More
Ex-Pfizer CEO’s startup Centrexion gets $67M for PhIII painkiller – Endpoints News
Centrexion Therapeutics, a Boston-based startup led by ex-Pfizer CEO Jeff Kindler, just raised $67 million to bring its painkiller drug into Phase III trials.…
Read More
Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018
Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-steroidal therapeutics for the treatment of chronic pain, today announced the successful completion of a…
Read More
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development | Markets Insider
NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners…
Read More
7 Key Cancer Trends For 2018
I expect progress. Here’s my list of major trends and issues that will affect the lives of cancer patients in 2018: {iframe}https://www.forbes.com/sites/elaineschattner/2017/12/31/7-key-cancer-trends-for-2018/#a6fde1a2d0e7{/iframe}
Read More
Hopkins-born startup PathoVax wins $2.5 million, nears clinical trial readiness – Baltimore Business Journal
The grants came through the National Institute of Allergy and Infectious Diseases and the National Science Foundation. {iframe}https://www.bizjournals.com/baltimore/news/2017/12/29/hopkins-born-biotech-startup-wins-2-5-million.html{/iframe}
Read More
Graduate School Open House Spring 2018 – FAES
Join us on Thursday, January 11 for the 2017-18 Spring Term FAES Graduate School Open House to meet and mingle with FAES faculty. Bring…
Read More
J.P. Morgan’s head of life sciences for commercial banking shares biopharma industry insights for 2018 (Q&A) – MedCity News
The biopharma sector has had quite a year. Under FDA Commissioner Scott Gottlieb, the regulator approved a record number of drugs and helped usher…
Read More
3 highlights from the FDA’s year in digital health
The FDA has released a range of decisions regarding the agency's role in regulating digital health technologies since Scott Gottlieb, MD, assumed the role…
Read More
DC Startup News: Tech Startup Funding, Investment in December
In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area.…
Read More
Geisinger CEO discusses telehealth, precision medicine and more – MedCity News
Dr. David Feinberg has served as president and CEO of Danville, Pennsylvania-based Geisinger since 2015. Previously, he was president of UCLA Health System, CEO…
Read More
| Year in Review: NEA ranks as most active investor in 2017
New Enterprise Associates made the most venture deals for the second year in a row in 2017, with 125 investments totaling $914 million, according…
Read More
Maryland’s Precision Medicine Group Lands $275M – BioSpace
Precision Medicine Group announced it had raised $275 million. The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders…
Read More
USM looks to commercialization to supplement federal research money – Maryland Daily Record
When the University System of Maryland set its strategic plan for the next 10 years in 2010, it hoped to double the system’s externally…
Read More
Sucampo Pharmaceuticals to be acquired by Mallinckrodt in $1.2B deal – Washington Business Journal
Global pharmaceutical company Mallinckrodt Plc (NYSE: MNK) has entered an agreement to buy Rockville’s Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) for $1.2 billion including debt.…
Read More